Literature DB >> 29126109

Do prospective payment systems (PPSs) lead to desirable providers' incentives and patients' outcomes? A systematic review of evidence from developing countries.

Si Ying Tan1, G J Melendez-Torres2.   

Abstract

The reform of provider payment systems, from retrospective to prospective payment, has been heralded as the right move to contain costs in the light of rising health expenditures in many countries. However, there are concerns on quality trade-off. The heightened attention given to prospective payment system (PPS) reforms and the rise of empirical evidence regarding PPS interventions among developing countries suggest that a systematic review is necessary to understand the effects of PPS reforms in developing countries. A systematic search of 14 databases and a hand search of health policy journals and grey literature from October to November 2016 were carried out, guided by a set of inclusion and exclusion criteria. Data were extracted based on the Consolidated Health Economics Evaluation Reporting Standards checklist. Drummond's 10-item checklist for economic evaluation, Cochrane Collaboration's tool in assessing risk of bias for randomized trials, and Risk of Bias in Non-randomized Studies of Interventions were used to critically appraise the evidence. A total of 12 studies reported in China, Thailand and Vietnam were included in this review. Substantial heterogeneity was present in PPS policy design across different localities. PPS interventions were found to have reduced health expenditures on both the supply and demand side, as well as length of stay and readmission rates. In addition, PPS generally improved service quality outcomes by reducing the likelihood or percentage of physicians prescribing unnecessary drugs and diagnostic procedures. PPS is a promising policy tool for middle-income countries to achieve reasonable health policy objectives in terms of cost containment without necessarily compromising the quality of care. More evaluations of PPS will need to be conducted in the future in order to broaden the evidence base beyond middle-income countries.
© The Author 2017. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Health care reform; health financing; health policy

Mesh:

Year:  2018        PMID: 29126109     DOI: 10.1093/heapol/czx151

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  4 in total

1.  Impacts of a New Episode-Based Payment Scheme on Volume, Expenditures, and Efficiency in Public Hospitals: A Quasi-Experimental Interrupted Time-Series Study in Jinhua, China.

Authors:  Tao Zhang; Beiyin Lu; Zhongheng Yan; Xiaojun Huang; Wei Lu
Journal:  Risk Manag Healthc Policy       Date:  2022-09-05

Review 2.  The Lancet Global Health Commission on financing primary health care: putting people at the centre.

Authors:  Kara Hanson; Nouria Brikci; Darius Erlangga; Abebe Alebachew; Manuela De Allegri; Dina Balabanova; Mark Blecher; Cheryl Cashin; Alexo Esperato; David Hipgrave; Ina Kalisa; Christoph Kurowski; Qingyue Meng; David Morgan; Gemini Mtei; Ellen Nolte; Chima Onoka; Timothy Powell-Jackson; Martin Roland; Rajeev Sadanandan; Karin Stenberg; Jeanette Vega Morales; Hong Wang; Haja Wurie
Journal:  Lancet Glob Health       Date:  2022-04-04       Impact factor: 38.927

3.  The impact of provider payment reforms and associated care delivery models on cost and quality in cancer care: A systematic literature review.

Authors:  Mina Nejati; Moaven Razavi; Iraj Harirchi; Kazem Zendehdel; Parisa Nejati
Journal:  PLoS One       Date:  2019-04-05       Impact factor: 3.240

4.  The effects of diagnosis-related groups payment on hospital healthcare in China: a systematic review.

Authors:  Kun Zou; Hong-Ying Li; Die Zhou; Zai-Jun Liao
Journal:  BMC Health Serv Res       Date:  2020-02-12       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.